23
Last reporting period 30 Jun, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.216
Exchange
XHKG - Hong Kong Exchange
0.19 B
Last period CFO ,CNY
63%
CFO has increased in 5 years
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also Dawnrays Pharmaceutical
Company Analysis
2348.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
2348.HK financial analysis by Eyestock methodology
Valuation
2348.HK valuation using historical relative method
Statements
2348.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
2348.HK dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
Dawnrays Pharmaceutical`s CFO for the period ended 2023-06-30 is 0.19 B CNY
